Evaluation of fully automated assays for the detection of Rubella IgM and IgG antibodies by the Elecsys® immunoassay system

Journal of Virological Methods

Volumn 199, Issue , 2014, Pages 108-115

  Van Helden, Josef ^a   Grangeot Keros, Liliane ^b   Vauloup Fellous, Christelle ^b   Vleminckx, Renaud ^c   Masset, Frédéric ^c   Revello, Maria Grazia ^d  

^a Division of Microbiology   (Germany)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c LABM BIOPATH Cité de l'Europe Ouest   (France)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Elecsys; Rubella screening; Sensitivity; Specificity

Indexed keywords

ELECSYS; RUBELLA SCREENING; SENSITIVITY; SPECIFICITY;

ANTIBODIES, VIRAL; AUTOMATION, LABORATORY; CLINICAL LABORATORY TECHNIQUES; FEMALE; FRANCE; GERMANY; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ITALY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPRODUCIBILITY OF RESULTS; RUBELLA; RUBELLA VIRUS; SENSITIVITY AND SPECIFICITY; VIROLOGY;

EID: 84894045956     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.01.009     Document Type: Article

References (24)

1. Banatvala J.E., Brown D.W. Rubella. Lancet 2004, 363:1127-1137.
2. Best J.M., O'Shea S., Tipples G., Davies N., Al-Khusaiby S.M., Krause A., Hesketh L.M., Jin L., Enders G. Interpretation of rubella serology in pregnancy - pitfalls and problems. BMJ 2002, 325:147-148.
3. Best J., Enders G. Laboratory diagnosis of rubella and congenital rubella. Rubella Viruses 2007, 39-79. Elsevier, Amsterdam. J.E. Banatvala, C. Peckham (Eds.).
4. Best J., Banatvala J.E. Rubella. Principles and Practice of Clinical Virology 2004, 427-458. John Wiley & Sons Ltd., Chichester, UK. A.J. Zuckerman, J.E. Banatvala, J.R. Pattison, P. Griffiths, B. Schoub (Eds.).
5. Cremer N.E., Devlin V.L., Riggs J.L., Hagens S.J. Anomalous antibody responses in viral infection: specific stimulation or polyclonal activation. J. Clin. Microbiol. 1984, 20:468-472.
6. Dimech W., Panagiotopoulos L., Francis B., Laven N., Marler J., Dickeson D., Panayotou T., Wilson K., Wootten R., Dax E.M. Evaluation of eight anti-rubella virus immunoglobulin G immunoassays that report results in international units per milliliter. J. Clin. Microbiol. 2008, 46:1955-1960.
7. Dontigny L., Arsenault M.Y., Martel M.J., Biringer A., Cormier J., Delaney M., Gleason T., Leduc D., Martel M.J., Penava D., Polsky J., Roggensack A., Rowntree C., Wilson A.K. Rubella in pregnancy. J. Obstet. Gynaecol. Can. 2008, 30:152-168.
8. Edlich R.F., Winters K.L., Long W.B., Gubler K.D. Rubella and congenital rubella (German measles). J. Long. Term Eff. Med. Implants 2005, 15:319-328.
9. Enders G., Knotek F. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 1989, 17:218-226.
10. Enders M., Bartelt U., Knotek F., Bunn K., Strobel S., Dietz K., Enders G. Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status. Clin Vaccine Immunol. 2013, 20(3):420-426.
11. Grangeot-Keros L., Pustowoit B., Hobman T. Evaluation of Cobas Core Rubella IgG EIA recomb, a new enzyme immunoassay based on recombinant rubella-like particles. J. Clin. Microbiol. 1995, 33:2392-2394.
12. Kaplan J.E., Benson C. Guidelines for prevention and treatment of opportunistic infections. In HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America 2009, 1-207. MMWR Recommendations and Reports 58(RR-4), Centers for Disease Control and Prevention (CDC).
13. Miller E., Cradock-Watson J.E., Pollock T.M. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982, 2:781-784.
14. Mubareka S., Richards H., Gray M., Tipples G.A. Evaluation of commercial rubella immunoglobulin G avidity assays. J. Clin. Microbiol. 2007, 47:231-233.
15. Pustowoit B., Grangeot-Keros L., Hobman T.C., Hofmann J. Evaluation of recombinant rubella-like particles in a commercial immunoassay for the detection of anti-rubella IgG. Clin. Diagn. Virol. 1996, 5:13-20.
16. Pustowoit B., Liebert U.G. Predictive value of serological tests in rubella virus infection during pregnancy. Intervirology 1998, 41:170-177.
17. Reef S.E., Frey T.K., Theall K., Abernathy E., Burnett C.L., Icenogle J., McCauley M.M., Wharton M. The changing epidemiology of rubella in the 1990: on the verge of elimination and new challenges for control and prevention. JAMA 2002, 287:464-472.
18. Scholz C., Thirault L., Schaarschmidt P., Zarnt T., Faatz E., Engel A.M., Upmeier B., Bollhagen R., Eckert B., Schmid F.X. Chaperone-aided in vitro renaturation of an engineered E1 envelope protein for detection of anti-Rubella virus IgG antibodies. Biochemistry 2008, 47:4276-4287.
19. Skendzel L.P. Rubella immunity defining the level of protective antibody. Am. J. Clin. Pathol. 1996, 106:170-174.
20. Skendzel L.P., Kiefer D.J., Nakamura R.M., Schaefer L.E., Stewart J.A. Detection and quantitation of Rubella IgG antibody: evaluation and performance criteria for multiple component test products, specimen handling, and use of test products in the clinical laboratory; Approved guideline 1997, 1-25. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
21. The European Parliament and the Council of the European Union Directive 2000/54/EC of the European Parliament and of the council 2000, 21-45. Publications Office of the European Union, Luxembourg.
22. Thomas H., Morgan-Capner P. Rubella specific IgG avidity: a comparison of methods. J. Virol. Methods 1991, 31:219-228.
23. World Health Organisation Rubella vaccines: WHO position paper. Wkly. Epidemiol. Rec. 2000, 75:161-172.
24. World Health Organisation Progress towards eliminating rubella and congenital rubella syndrome in the western hemisphere, 2003-2008. Wkly. Epidemiol. Rec. 2000, 83:395-400.